We advocate for patient safety and equal access to medical information. Stay informed about EU pharmaceutical legislation updates and medical leaflets.
Print on Demand can result in serious health threats to patients. It is subject to:
๐จ๏ธtechnical failure - printers failing
๐จโโ๏ธhuman error - pharmacist need to ensure the right leaflet is printed
โchances of the leaflet being associated with the wrong medicine
In a ๐without paper leaflets, access to digital tools is essential. However, even in countries with high smartphone usage such as Denmark๐ฉ๐ฐ, up to 25% of the population do not own a๐ฑ
โผ๏ธ Paper leaflets are crucial to ensure equitable access to healthcare information โผ๏ธ
Print on Demand is not a good option for patient information leaflets:
โUnworkable in practice
โ๏ธImposes additional burdens on pharmacies
๐ธCost impact is 2 to 3 times larger than the current system
More on the risks of POD for pharmaceutical leaflets ๐https://t.co/2L4Yw07Akw
๐๐ต Limited access to internet or smartphones and lack of skills hinder access to e-leaflets, leaving patients without access to crucial healthcare information
To ensure patient safety, we need a balanced approach with both paper and e-leaflets
More ๐ https://t.co/6QigIF0yZC
Are we ready to eliminate paper leaflets? Shifting to digital-only options could leave many patients at risk, especially those without digital access. Print on Demand sounds good, but it brings added costs and potential safety issues. . #PatientSafety#DigitalInclusion
๐ข Ensuring Patient Safety! Only 54% of Europeans have basic digital skills, making paper leaflets crucial. We urge policymakers to retain both paper & e-leaflets for inclusive healthcare. ๐ @EU_Commission@EPPGroup@TheProgressives
๐ [MLPS Manifesto](https://t.co/J2pAAIwTA8)
@IntergrafAISBL report aligns with MLPS! Print & digital both vital: ๐ sustainability, ๐ reading, ๐ marketing, ๐ digital divide. Read more: https://t.co/zWa4gCYkmA
New study on public preferences on digital medicine info by @aesgp!
Over 80% of respondents favoured physical leaflets for crucial information like dosage, uses, warnings, and side effects. Read moreโก๏ธ https://t.co/SHJVNKvlna
#DigitalHealth#PatientEducation
A study published earlier this year sheds light on the significant financial implications of implementing print-on-demand (PoD) leaflets for medications across Europe.
https://t.co/UkZU4owhCY
PoD for Med Info? Think Again! โ Burdens Pharmacists & costs! Regular printers risk errors! ๐ท Separate leaflets get lost! Say NO to PoD! #PatientSafety
Learn more: https://t.co/UkZU4owhCY
@IntergrafAISBL welcomes the release of aย studyย by our partner @mlpsleaflet, a subgroup of @ECMAorg, shedding light on the potential economic costs associated with the proposed use of #PrintOnDemand (PoD).
Read the report at: https://t.co/HRW0y39yqI
#packaging#sutainability
@ABDA_Berlin: make sure "pharmacies do not become printing presses. This is both ecologically and economically nonsensical." ๐จ๏ธ
https://t.co/dQrrhTqtPT
Myth busted! PoD is NOT the answer for medication leaflets โโ๏ธ
- Puts strain on pharmacies, raising costs ๏ธ
- Risk of errors with desktop printers = patient safety risk
- Separate leaflets = higher chance of getting lost
https://t.co/BkERI3o15C
There's an environmental impact when anything is accessed online - including ePIs. The global digital ecosystem is said to emit twice as much as all air travel!
While a full comparison of ePI vs paper leaflets is still needed, here are some things to consider:
Our study reveals hidden costs of Print-on-Demand leaflets in revised Med. Dir.! PoD could cost โฌ1.68-โฌ3.49 billion annually across Europe! ๐ช๐บ Who will bear these costs? #MedicinesDirective#PoD#ePI#HealthcareCosts
Read more: https://t.co/2wBfpXftN9
According to a case study set in France the cost to print a single PoD leaflet would be between 1,13 โฌ and 2,13 โฌ, depending on colours and printer used! ๐ถ ๐ถ ๐ถ
This could add up to over 730 million โฌ just in France alone.
Read more about this here: https://t.co/2wBfpXftN9